Your browser doesn't support javascript.
loading
Hexosamine Biosynthetic Pathway Inhibition Leads to AML Cell Differentiation and Cell Death.
Asthana, Abhishek; Ramakrishnan, Parameswaran; Vicioso, Yorleny; Zhang, Keman; Parameswaran, Reshmi.
Affiliation
  • Asthana A; Division of Hematology/Oncology, Department of Medicine, Case Western Reserve University, 2103 Cornell Road, Cleveland, Ohio.
  • Ramakrishnan P; Department of Pathology, Case Western Reserve University, Cleveland, Ohio.
  • Vicioso Y; The Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio.
  • Zhang K; Department of Pathology, Case Western Reserve University, Cleveland, Ohio.
  • Parameswaran R; Division of Hematology/Oncology, Department of Medicine, Case Western Reserve University, 2103 Cornell Road, Cleveland, Ohio.
Mol Cancer Ther ; 17(10): 2226-2237, 2018 10.
Article in En | MEDLINE | ID: mdl-30082471
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Cell Differentiation / Biosynthetic Pathways / Hexosamines Limits: Animals / Humans Language: En Journal: Mol Cancer Ther Journal subject: ANTINEOPLASICOS Year: 2018 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Cell Differentiation / Biosynthetic Pathways / Hexosamines Limits: Animals / Humans Language: En Journal: Mol Cancer Ther Journal subject: ANTINEOPLASICOS Year: 2018 Document type: Article Country of publication: United States